1. Home
  2. NRSN vs SKYQ Comparison

NRSN vs SKYQ Comparison

Compare NRSN & SKYQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • SKYQ
  • Stock Information
  • Founded
  • NRSN 2017
  • SKYQ 2019
  • Country
  • NRSN Israel
  • SKYQ United States
  • Employees
  • NRSN N/A
  • SKYQ N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • SKYQ
  • Sector
  • NRSN Health Care
  • SKYQ
  • Exchange
  • NRSN Nasdaq
  • SKYQ NYSE
  • Market Cap
  • NRSN 17.8M
  • SKYQ 16.9M
  • IPO Year
  • NRSN 2021
  • SKYQ N/A
  • Fundamental
  • Price
  • NRSN $1.14
  • SKYQ $0.98
  • Analyst Decision
  • NRSN Hold
  • SKYQ
  • Analyst Count
  • NRSN 1
  • SKYQ 0
  • Target Price
  • NRSN N/A
  • SKYQ N/A
  • AVG Volume (30 Days)
  • NRSN 360.5K
  • SKYQ 230.9K
  • Earning Date
  • NRSN 12-31-2024
  • SKYQ 02-14-2025
  • Dividend Yield
  • NRSN N/A
  • SKYQ N/A
  • EPS Growth
  • NRSN N/A
  • SKYQ N/A
  • EPS
  • NRSN N/A
  • SKYQ N/A
  • Revenue
  • NRSN N/A
  • SKYQ $30,766,012.00
  • Revenue This Year
  • NRSN N/A
  • SKYQ N/A
  • Revenue Next Year
  • NRSN N/A
  • SKYQ N/A
  • P/E Ratio
  • NRSN N/A
  • SKYQ N/A
  • Revenue Growth
  • NRSN N/A
  • SKYQ N/A
  • 52 Week Low
  • NRSN $0.51
  • SKYQ $0.82
  • 52 Week High
  • NRSN $2.33
  • SKYQ $5.49
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 56.63
  • SKYQ N/A
  • Support Level
  • NRSN $0.80
  • SKYQ N/A
  • Resistance Level
  • NRSN $1.29
  • SKYQ N/A
  • Average True Range (ATR)
  • NRSN 0.13
  • SKYQ 0.00
  • MACD
  • NRSN 0.01
  • SKYQ 0.00
  • Stochastic Oscillator
  • NRSN 68.75
  • SKYQ 0.00

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About SKYQ SKY QUARRY INC

Sky Quarry Inc is a development-stage oil-producing and refining company. The company along with its subsidiaries is engaged in deploying technologies to facilitate the recycling of waste asphalt shingles and remediation of oil-saturated soils. The recycling and production of oil from asphalt shingles is expected to reduce the dependence on landfills for the disposal of waste and to also reduce dependence on foreign and domestic virgin crude oil extraction for industrial uses.

Share on Social Networks: